Back9 Meters Biopharma Overview

9 Meters Biopharma Current Cash

9 Meters Biopharma's current cash is $6.9M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$6.94M
↓ 81.37% YoYΔ $-30.30M vs prior year quarter

Peer trimmed avg / median

Loading

9 Meters Biopharma Current Cash History

Loading

9 Meters Biopharma vs. peers: Current Cash Comparison

Loading

9 Meters Biopharma Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

9 Meters Biopharma (NMTRQ) FAQ

The latest current cash for NMTRQ is $6.9M as of March 2023. That compares with $37M in the prior-year period — down 81.4% year over year. Investors often review this figure alongside 9 Meters Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, NMTRQ's current cash moved from $37M to $6.9M — a 81.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 9 Meters Biopharma's operating scale or balance-sheet position.

A current cash figure of $6.9M for NMTRQ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NMTRQ's current cash ($6.9M), review year-over-year change from $37M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 9 Meters Biopharma's current cash against similar Technology names. You can also browse sector and industry screens on Stockcircle for a broader set of Technology companies and their key multiples and fundamentals.